BioGaia ProTectis baby drops and the BioGaia ProTectis tablets contain BioGaia’s patented and researched probiotic strain Lactobacillus reuteri Protectis. BioGaia Gastrus is a new product that is currently
As per the terms of the license and development agreement, Toyama will have exclusive rights to develop and commercialize solithromycin in Japan. Cempra will receive an upfront payment
Reprints Desk’s Sunshine ePrints solution simplifies Sunshine Act compliance for the use of medical ePrints for sales, marketing and medical affairs. The solution records the delivery of each
The first fully human monoclonal antibody Sarilumab is directed against the IL-6 receptor and delivered by subcutaneous injection every other week. Regeneron Laboratories president and Regeneron chief scientific
The CMC’s CHEF1 high-productivity expression plasmid will be leveraged for the cell line development to optimize cell growth, and consistent, high-level protein expression in a rapid time frame.
IGDRASOL had earlier acquired exclusive US distribution rights to Cynviloq, which is a next-generation, branded, micellar diblock copolymeric paclitaxel formulation currently approved and marketed in several countries, including
The entity group that includes affiliates of Greenspring Associates, QIC Global Private Equity, and Thomas McNerney & Partners was formed to acquire the AmerisourceBergen’s contract packaging business. The
The company and its affiliates agreed to settle the alleged civil violations of the False Claims Act with the US. Ranbaxy USA has agreed to plead guilty to
The rejection follows the company’s previously dismissed proposal to install wind turbines at the facility. The company, which has accepted the decision, is working with Marine Scotland to
As per the agreement, the new JV will be named Amgen-Beta Pharmaceuticals and Zhejiang Beta Pharma will own 51% while Amgen will own the remaining 49% interest in
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.